DOM

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-09-24srcThe origin of 2,5-dimethoxy-4-methylamphetamine (DOM, STP)
4. 2026-09-24srcMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
5. 2026-09-24srcCorrelation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
6. 2026-09-24srcInvestigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists
7. 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
8. 2026-09-24srcDiscriminative Stimulus Effects of Substituted Tryptamines in Rats
9. 2026-09-24src1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.
10. 2026-09-24srcThe 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects
11. 2026-09-24srcLocomotor and discriminative stimulus effects of four novel hallucinogens in rodents
12. 2026-09-24srcLocomotor and discriminative stimulus effects of NBOH hallucinogens in rodents
13. 2026-09-24srcDiscriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
14. 2026-09-24srcDifferential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.
15. 2026-09-24srcAbuse liability profile of three substituted tryptamines
16. 2026-09-24srcTolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
17. 2026-09-24srcPsychedelics
18. 2026-09-24src2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug
19. 2026-09-24srcPsychedelics and the human receptorome
20. 2026-09-24srcA 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat
21. 2026-09-24srcEffects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas
22. 2026-09-24srcRapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists
23. 2026-09-24src2,5-Dimethoxy-4-methylamphetamine (DOM)- a central component of its cardiovascular effects in rats; involvement of serotonin
24. 2026-09-24srcThe discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine
25. 2026-09-24srcStudies on chiral interactions of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane and the corresponding N-hydroxy metabolites with cytochrome P-450
26. 2026-09-24srcPiHKAL #68: DOM
27. 2026-09-24src2,5-Dimethoxy-4-methylamphetamine - Wikipedia
28. 2026-09-04issueIssued emergency
29. 2026-09-04issueIssued info_card
30. 2026-09-04issueIssued notice
31. 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
32. 2026-06-04publicationPublication — backfill
33. 2026-04-26revisionRevision 1
34. 2026-04-26absenceSearched ClinicalTrials.gov for "DOM 2,5-dimethoxy-4-methylamphetamine psychedelic" — no results
35. 2026-04-26absenceSearched PubMed for "DOM STP hallucinogen drug discrimination 5-HT2A serotonin" — no results
36. 2026-04-26genGeneration — pipeline-v5pipeline-v5
37. 2026-04-26rungeneration run

The same entries, as forms: six forms.